Page last updated: 2024-11-01

nimodipine and Aortitis Syndrome

nimodipine has been researched along with Aortitis Syndrome in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research Excerpts

ExcerptRelevanceReference
"We report four young women with Takayasu's arteritis who developed an ischemic stroke."1.29[Cerebrovascular complications of Takayasu's disease]. ( del Brutto, OH; Lara-Montiel, J; Lara-Terán, J; Sánchez, J, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
del Brutto, OH1
Lara-Terán, J1
Sánchez, J1
Lara-Montiel, J1

Other Studies

1 other study available for nimodipine and Aortitis Syndrome

ArticleYear
[Cerebrovascular complications of Takayasu's disease].
    Revista de neurologia, 1996, Volume: 24, Issue:131

    Topics: Adolescent; Adult; Blood Sedimentation; Brain; Calcium Channel Blockers; Cerebral Angiography; Cereb

1996